Foundation Funding

NEW FUNDING OPPORTUNITIES

Improved Biomarkers and Clinical Outcome Measures Program

The Michael J. Fox Foundation for Parkinson’s Research

Amount: $750,000

Deadline: 26 Sep 2018 Preliminary Proposal; 22 Jan 2019 Full Proposal

Indirect Overhead Rate: 10%

 

Summary: The Michael J. Fox Foundation (MJFF) seeks to support research that will develop biomarker tools and clinical outcome measures to assist in diagnosis and therapeutic development and ultimately inform clinical trial design, execution and interpretation of results. Part of our Edmond J. Safra Core Programs for PD Research, the Improved Biomarker and Clinical Outcome Measure program funds research to develop or optimize imaging, clinical, non-invasive or biochemical biomarkers.

 

Funding will be directed to projects that will improve the precision of measuring Parkinson’s disease in humans. This could include enriching subject populations in clinical trials, developing markers of target engagement, or discovery or validation of objective outcomes that track disease progression.

 

Applications must focus on developing robust and precise biomarker measures (e.g., imaging, physiological or biochemical assays), clinical outcome measures, and/or scale development (e.g. predictive modeling) for PD.

 

Eligibility: Applications may be submitted by researchers or clinicians in:

  • U.S. and non-U.S. biotechnology/pharmaceutical companies, or other publicly or privately held for-profit entities; and
  • U.S. and non-U.S. public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and eligible agencies of the federal government.
  • Post-doctoral fellows are eligible to apply as co-investigators with the designation of an administrative principal investigator who directs the laboratory in which the fellow will conduct research. The administrative PI will be responsible for assisting in providing all institutional documents required for the project and will be required to sign any award contract. Training or mentoring-only proposals will not be considered.

 

 

Target Advancement Program

The Michael J. Fox Foundation for Parkinson’s Research

Amount: $150,000

Deadline: 26 Sep 2018 Preliminary Proposal; 22 Jan 2019 Full Proposal

Indirect Overhead Rate: 10%

 

Summary: The Michael J. Fox Foundation believes that a major hurdle in the development of promising treatments for Parkinson’s disease (PD) is the need for well-validated targets linked to the disease process. By promoting critical target validation studies within academic and industry laboratories, MJFF investments can help de-risk subsequent drug development and ultimately accelerate the advancement of innovative therapies for Parkinson’s patients. Part of our Edmond J. Safra Core Programs for PD Research, the Target Advancement program seeks to build robust evidence to rationalize biological pathways and targets for further translation into new Parkinson’s treatments.

 

Target Advancement awards support research characterizing promising, novel PD-relevant targets or continuing target biology work on established PD targets. Preferred targets for this program already demonstrate links to PD in human patient populations. These awards are well-suited to projects in which hypothetical or experimental rationale for a target is compelling but limited, and study results can make the case for continuing (or discontinuing) a line of research.

 

Eligibility: Applications may be submitted by researchers or clinicians in:

  • U.S. and non-U.S. biotechnology/pharmaceutical companies, or other publicly or privately held for-profit entities; and
  • U.S. and non-U.S. public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and eligible agencies of the federal government.
  • Post-doctoral fellows are eligible to apply as co-investigators with the designation of an administrative primary investigator who directs the laboratory in which the fellow will conduct research. The administrative PI will be responsible for assisting in providing all institutional documents required for the project and will be required to sign any award contract. Training or mentoring-only proposals will not be considered.

 

 

The Hilda and Preston Davis Foundation Awards Program for Eating Disorders Research: Junior Faculty

Health Resources in Action (HRiA)

Amount: $200,000

Deadline: 28 Sep 2018 Preliminary Proposal

Indirect Overhead Rate: 5%

 

Summary: The primary goal of the new Hilda and Preston Davis Foundation Awards Program for Eating Disorders Research is to support innovative, clinically relevant research that seeks to understand the underlying biology of eating disorders, including anorexia nervosa and bulimia nervosa, leading to improved patient care. Clinical trials, obesity research, and binge eating research are outside the scope of the program.

 

Eligibility:

  • Applicants must hold a Ph.D., M.D., or comparable degree and work at a non-profit academic, medical or research institution in the United States;
  • Applicants must have a full-time independent faculty appointment and their first faculty appointment must have been received no more than five (5) years prior to the award’s funding start date.

 

 

Clinical Research Training Scholarships

Muscular Dystrophy Association (MDA)

Amount: $130,000

Deadline: 01 Oct 2018

Indirect Overhead Rate: 15%

 

Summary: MDA is committed to supporting investigators who are at an early stage in their medical careers with the goal to encourage talented physicians to enter the field of academic clinical neuromuscular research. In partnership with the American Academy of Neurology (AAN) and the American Brain Foundation (ABF), MDA is pleased to offer a Clinical Research Training Fellowship opportunity.

 

Eligibility:

  • Applicants must have an M.D. and must have completed residency within the past five years of the start date of the award (July 1)
  • Applicants must be a member of the AAN interested in an academic career in clinical research

 

 

Young Investigator Awards

Melanoma Research Alliance

Amount: $225,000

Deadline: 02 Nov 2018

Indirect Overhead Rate: 0%

 

Summary: Young Investigator Awards aim to attract early career faculty with original ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders. Awardees will be provided funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects.

 

Eligibility:

  • Applicants must be within the first four years of their first independent, full time academic faculty appointment at the application deadline at the level of Assistant Professor (or equivalent position).
  • Applicants must designate at least one Mentor who is an established investigator at the same institution who will ensure that adequate support and guidance are provided for successful completion of the proposed research project and provide career mentorship.
  • Applicants who have secured an independent full-time faculty position commencing by July 1, 2019, will be considered; in this case, a letter from an institutional official or department chairperson confirming the planned date of faculty appointment is required at the time of application.
  • Applicants do not have to be on a tenure-track; however, fellows or others who are in training positions are not eligible to apply. Applicants who are in research support positions are not eligible to apply.
  • Applicants who have been awarded a prior MRA Young Investigator Award are not eligible to apply for an additional MRA Young Investigator Award.
  • Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle.

 

 

Special Opportunity: MRA Young Investigator Award and MRA Established Investigator Awards for Artificial Intelligence Applied to Melanoma

Melanoma Research Alliance

Amount: $225,000 – $375,000

Deadline: 02 Nov 2018

Indirect Overhead Rate: 0%

 

Summary: Advances in artificial intelligence (AI) are rapidly impacting the oncology landscape, with potential applications in target identification and development, medical and diagnostic imaging, prognostics and clinical decision making, among others. MRA seeks to support research efforts that use AI to advance melanoma detection, prevention, diagnosis, staging, and/or treatment by offering two AI-focused Established Investigator Awards and one Young Investigator Award.

 

While any proposal that applies AI to melanoma will be considered, priority will be given to proposals addressing following applications:

  • Melanoma diagnosis: Improving the detection and/or diagnosis of melanoma from digital images, including dermatopathology images
  • Prognostic indicators for melanoma patient outcomes: Analyzing diverse datasets to identify novel biomarkers for patient prognosis and/or response to treatment
  • Discovery of novel drug targets: Identifying novel drug candidates for melanoma through AI-driven data analysis

 

Eligibility: Young Investigator Awards Requirements:

  • Applicants must be within the first four years of their first independent, full time academic faculty appointment at the application deadline at the level of Assistant Professor (or equivalent position).
  • Applicants must designate at least one Mentor who is an established investigator at the same institution who will ensure that adequate support and guidance are provided for successful completion of the proposed research project and provide career mentorship.
  • Applicants who have secured an independent full-time faculty position commencing by July 1, 2019, will be considered; in this case, a letter from an institutional official or department chairperson confirming the planned date of faculty appointment is required at the time of application.
  • Applicants do not have to be on a tenure-track; however, fellows or others who are in training positions are not eligible to apply. Applicants who are in research support positions are not eligible to apply.
  • Applicants who have been awarded a prior MRA Young Investigator Award are not eligible to apply for an additional MRA Young Investigator Award.
  • Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle.

 

Established Investigator Awards Requirements:

  • Applicants must be a senior investigator, past the initial four years of their first academic faculty appointment.
  • Applicants must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above.

General Eligibility Requirements:

  • MRA encourages applications from a diverse pool of investigators.
  • Principal Investigators (PIs) must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above at an academic or other nonprofit research institution within or outside the United States.

 

  • PIs must be able to show clear evidence of an independent research program.
  • Fellows or those in other training or research support positions are not eligible to apply.
  • Individuals employed by state or federal government agencies may participate in research proposals as non-funded collaborators but may not apply for MRA funding.
  • Investigators need not be specifically trained in melanoma research; however, they should be working in an environment capable of conducting high -quality, high-impact melanoma research.
  • An investigator may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle. This includes any Special Opportunity Awards.
  • Mentors for Young Investigator or ASTRO-MRA Early Career Award applicants may serve as a PI on separate proposal this cycle; however, that proposal must represent a distinct hypothesis from the Young Investigator’s or Early Career Investigator’s proposal.

 

 

Special Opportunity: MRA Young Investigator Award and MRA Established Investigator Award in Dermatology

Melanoma Research Alliance

Amount: $225,000 – $375,000

Deadline: 02 Nov 2018

Indirect Overhead Rate: 0%

 

Summary: With this Special Opportunity, MRA is offering one Young Investigator Award and one Established Investigator Award to support academic research carried out by dermatology faculty.

 

Research proposals can focus on prevention, diagnosis, and/or treatment of melanoma, and may include research related to dermatology, dermatopathology, and/or dermatologic surgery.

 

Eligibility: Eligible applicants must hold an appointment in a department or division of dermatology.

Young Investigator Awards Requirements:

  • Applicants must be within the first four years of their first independent, full time academic faculty appointment at the application deadline at the level of Assistant Professor (or equivalent position).
  • Applicants must designate at least one Mentor who is an established investigator at the same institution who will ensure that adequate support and guidance are provided for successful completion of the proposed research project and provide career mentorship.
  • Applicants who have secured an independent full-time faculty position commencing by July 1, 2019, will be considered; in this case, a letter from an institutional official or department chairperson confirming the planned date of faculty appointment is required at the time of application.
  • Applicants do not have to be on a tenure-track; however, fellows or others who are in training positions are not eligible to apply. Applicants who are in research support positions are not eligible to apply.
  • Applicants who have been awarded a prior MRA Young Investigator Award are not eligible to apply for an additional MRA Young Investigator Award.
  • Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle.

 

Established Investigator Awards Requirements:

  • Applicants must be a senior investigator, past the initial four years of their first academic faculty appointment.
  • Applicants must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above.

 

General Eligibility Requirements:

  • MRA encourages applications from a diverse pool of investigators.
  • Principal Investigators (PIs) must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above at an academic or other nonprofit research institution within or outside the United States.
  • PIs must be able to show clear evidence of an independent research program.
  • Fellows or those in other training or research support positions are not eligible to apply.
  • Individuals employed by state or federal government agencies may participate in research proposals as non-funded collaborators but may not apply for MRA funding.
  • Investigators need not be specifically trained in melanoma research, however, they should be working in an environment capable of conducting high -quality, high-impact melanoma research.
  • An investigator may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle. This includes any Special Opportunity Awards.
  • Mentors for Young Investigator or ASTRO-MRA Early Career Award applicants may serve as a PI on separate proposal this cycle; however, that proposal must represent a distinct hypothesis from the Young Investigator’s or Early Career Investigator’s proposal.

 

 

 

Special Opportunity: Bristol-Myers Squibb-MRA Young Investigator Awards in Immunotherapy

Melanoma Research Alliance

Amount: $225,000

Deadline: 02 Nov 2018

Indirect Overhead Rate: 0%

 

Summary: Through the generous support of Bristol-Myers Squibb (BMS), MRA is offering two awards for Young Investigators to conduct projects supported by preliminary data and focused on advancing immunotherapies in melanoma.

 

Eligibility: Young Investigator Awards Requirements:

  • Applicants must be within the first four years of their first independent, full time academic faculty appointment at the application deadline at the level of Assistant Professor (or equivalent position).
  • Applicants must designate at least one Mentor who is an established investigator at the same institution who will ensure that adequate support and guidance are provided for successful completion of the proposed research project and provide career mentorship.
  • Applicants who have secured an independent full-time faculty position commencing by July 1, 2019, will be considered; in this case, a letter from an institutional official or department chairperson confirming the planned date of faculty appointment is required at the time of application.
  • Applicants do not have to be on a tenure-track; however, fellows or others who are in training positions are not eligible to apply. Applicants who are in research support positions are not eligible to apply.
  • Applicants who have been awarded a prior MRA Young Investigator Award are not eligible to apply for an additional MRA Young Investigator Award.
  • Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle.

 

General Eligibility Requirements:

  • MRA encourages applications from a diverse pool of investigators.
  • Principal Investigators (PIs) must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above at an academic or other nonprofit research institution within or outside the United States.
  • PIs must be able to show clear evidence of an independent research program.
  • Fellows or those in other training or research support positions are not eligible to apply.
  • Individuals employed by state or federal government agencies may participate in research proposals as non-funded collaborators but may not apply for MRA funding.
  • Investigators need not be specifically trained in melanoma research, however, they should be working in an environment capable of conducting high -quality, high-impact melanoma research.
  • An investigator may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle. This includes any Special Opportunity Awards.
  • Mentors for Young Investigator or ASTRO-MRA Early Career Award applicants may serve as a PI on separate proposal this cycle; however, that proposal must represent a distinct hypothesis from the Young Investigator’s or Early Career Investigator’s proposal.

 

Special Opportunity: ASTRO-MRA Early Career Investigator Award in Radiation Oncology

Melanoma Research Alliance

Amount: $200,000

Deadline: 09 Nov 2018

Indirect Overhead Rate: 0%

 

Summary: Research in radiation oncology has led to advancements in technology and therapy that have improved patient outcomes and care. The MRA is pleased to partner with the American Society for Radiation Oncology (ASTRO) to offer a special opportunity to support research in radiation oncology to improve treatment options for melanoma patients. Early career radiation oncologists, radiation or cancer biologists, or a physicists are encouraged to submit radiation oncology Research Proposals that include at least 50% effort on melanoma.

 

Eligibility: Specific ASTRO-MRA Early Career Investigator Award Requirements:

  • Applicants must be within the first five years of their first independent, full time academic faculty appointment at the application deadline at the level of Assistant Professor (or equivalent position).
  • Applicants must hold a position at an academic or other nonprofit research institution within the United States.
  • Applicants must be a member in good standing of ASTRO.
  • Applicants must designate at least one Mentor who is an established investigator at the same institution who will ensure that adequate support and guidance are provided for successful completion of the proposed research project and provide career mentorship.
  • Applicants who have secured an independent full-time faculty position commencing by July 1, 2019, will be considered; in this case, a letter from an institutional official or department chairperson confirming the planned date of faculty appointment is required at the time of application.
  • Applicants do not have to be on a tenure-track; however, fellows or others who are in training positions are not eligible to apply.
  • Applicants who are in research support positions are not eligible to apply.
  • Applicants who have been awarded a prior MRA Young Investigator Award are not eligible to apply for an ASTRO-MRA Early Career Investigator Award.
  • Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle.

 

General eligibility requirements:

  • MRA encourages applications from a diverse pool of investigators.
  • Principal Investigators (PIs) must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above at an academic or other nonprofit research institution within or outside the United States. Please note, however, that the ASTRO-MRA Early Career Investigator Award is limited to U.S. applicants only.
  • PIs must be able to show clear evidence of an independent research program.
  • Fellows or those in other training or research support positions are not eligible to apply.
  • Individuals employed by state or federal government agencies may participate in research proposals as non-funded collaborators but may not apply for MRA funding.
  • Investigators need not be specifically trained in melanoma research; however, they should be working in an environment capable of conducting high-quality, high-impact melanoma research.
  • An investigator may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle. This includes any Special Opportunity Awards.
  • Mentors for Young Investigator or ASTRO-MRA Early Career Award applicants may serve as a PI on separate proposal this cycle; however, that proposal must represent a distinct hypothesis from the Young Investigator’s or Early Career Investigator’s proposal.
  • Multiple applications will be accepted from a single institution, provided that each application has a different PI and represents a distinct hypothesis.

 

 

Pilot Award

Melanoma Research Alliance

Amount: $100,000

Deadline: 02 Nov 2018

Indirect Overhead Rate: 0%

 

Summary: Pilot Awards support senior investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues.

 

Eligibility: Pilot Award Requirements:

  • Applicants must be a senior investigator, past the initial four years of their first academic faculty appointment.
  • Applicants must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above.

 

General Eligibility Requirements:

  • MRA encourages applications from a diverse pool of investigators.
  • Principal Investigators (PIs) must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above at an academic or other nonprofit research institution within or outside the United States.
  • PIs must be able to show clear evidence of an independent research program.
  • Fellows or those in other training or research support positions are not eligible to apply.
  • Individuals employed by state or federal government agencies may participate in research proposals as non-funded collaborators but may not apply for MRA funding.
  • Investigators need not be specifically trained in melanoma research; however, they should be working in an environment capable of conducting high -quality, high-impact melanoma research.
  • An investigator may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle. This includes any Special Opportunity Awards.
  • Mentors for Young Investigator or ASTRO-MRA Early Career Award applicants may serve as a PI on separate proposal this cycle; however, that proposal must represent a distinct hypothesis from the Young Investigator’s or Early Career Investigator’s proposal.

 

 

Established Investigator Awards

Melanoma Research Alliance

Amount: $375,000

Deadline: 02 Nov 2018

Indirect Overhead Rate: 0%

 

Summary: Established Investigator Awards support senior investigators with an established record of scientific productivity and accomplishment.

 

Eligibility: Established Investigator Awards Requirements:

  • Applicants must be a senior investigator, past the initial four years of their first academic faculty appointment.
  • Applicants must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above.

 

General Eligibility Requirements:

  • MRA encourages applications from a diverse pool of investigators.
  • Principal Investigators (PIs) must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above at an academic or other nonprofit research institution within or outside the United States.
  • PIs must be able to show clear evidence of an independent research program.
  • Fellows or those in other training or research support positions are not eligible to apply.
  • Individuals employed by state or federal government agencies may participate in research proposals as non-funded collaborators but may not apply for MRA funding.
  • Investigators need not be specifically trained in melanoma research; however, they should be working in an environment capable of conducting high -quality, high-impact melanoma research.
  • An investigator may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle. This includes any Special Opportunity Awards.
  • Mentors for Young Investigator or ASTRO-MRA Early Career Award applicants may serve as a PI on separate proposal this cycle; however, that proposal must represent a distinct hypothesis from the Young Investigator’s or Early Career Investigator’s proposal.

 

 

Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Grant Programme

International AIDS Society

Amount: $150,000

Deadline: 26 Oct 2018 LOI; 25 Jan 2019 Application

Indirect Overhead Rate: Allowed; rate not indicated

 

Summary: The CIPHER Grant Programme directly supports the development of early-stage investigators, awarding grants to address research gaps in paediatric and adolescent HIV in resource-limited settings.

 

CIPHER has three primary objectives:

  • Promote and invest in targeted research to address priority knowledge gaps in paediatric HIV
  • Convene stakeholders and facilitate collaboration to strengthen communication, knowledge transfer and exchange among paediatric HIV cohorts
  • Undertake advocacy to support evidence-informed clinical, policy and programmatic decision making.

 

Eligibility: The principal investigator (PI) must be an early-stage investigator, i.e., an individual who obtained her/his terminal research degree (e.g., PhD, MD followed by research training, or MBBS) less than 10 years before the application deadline.

The PI must serve for the first time as primary PI. Primary PIs who previously received a non-training research grant exceeding US$ 30,000 are not eligible.

The PI must fulfil one of the following criteria prior to the submission deadline for the Letter of Intent (LOI):

  • He/she is a clinical/research trainee (e.g., fellow, senior resident) at an academic institute or an institute whose primary mission is research.
  • He/she has a faculty or comparable position (e.g., assistant professor, lecturer) at an academic institute or an institute whose primary mission is research.
  • He/she has an established position at an organization with adequate research infrastructure to undertake the proposed research activities.

Applications are encouraged from any country, but approximately 80 percent of available funds in any given year will be awarded to applicants from (meaning holding a passport from) low- and middle-income countries (LMICs) according to the World Bank classification.

Principal investigators are allowed to submit more than one application, but under no circumstances, the PI will receive more than one grant.

 

 

Harry Shwachman Clinical Investigator Award

Cystic Fibrosis Foundation (CFF)

Amount: $330,000

Deadline: 15 Feb 2019

Indirect Overhead Rate: 0%

 

Summary: The Harry Shwachman CF Clinical Investigator Award provides the opportunity for promising, clinically-trained physicians with a commitment to research to develop into independent biomedical researchers who have active involvement in CF-related areas. The award helps facilitate the transition from postdoctoral training to an academic career as an independent investigator. The award enables candidates to undertake three years of research, tailored to the individual’s interests and needs, with a sponsor(s) who is/are competent to provide appropriate research guidance and supervision.

 

Eligibility:

  • Candidates must be U.S. citizens or U.S. permanent residents (must have obtained permanent residency prior to the time of application)
  • Junior faculty and senior fellows are eligible to apply
  • In general, a successful candidate has: (i) previous relevant research training; (ii) expertise in a related research technique; and (iii) a minimum of one (1) manuscript or abstract accepted for publication

ONGOING OPPORTUNITIES

​Please note that some of the opportunities below may have sponsor IDC rates that fall below the new Partners IDC floor of 15%.  Please consider whether the resources exist within your Division/Department to cover the Partners minim.um IDC rate of 15% before planning to apply for these awards.  For more information on the IDC floor, review the new F&A Policy online.

Beckman-Argyros Award in Vision Research

Arnold and Mabel Beckman Foundation

Amount: $500,000

Deadline: 28 Sep 2018

 

Global Oncology Young Investigator Award

Conquer Cancer Foundation/American Society of Clinical Oncology (ASCO)

Amount: $50,000

Deadline: 25 Sep 2018

Indirect Overhead Rate: 10%

 

Charles & Daneen Stiefel Scholar Award

Dermatology Foundation

Amount: $300,000

Deadline: 17 Sep 2018

Indirect Overhead Rate: 0%

 

ACC Presidential Career Development Award

American College of Cardiology (ACC)

Amount: $70,000

Deadline: 21 Sep 2018

Indirect Overhead Rate: Not listed

 

Ovarian Cancer Research Grant in Honor of Liza D. Chance

Society of Gynecologic Oncology/Foundation for Women’s Cancer

Amount: $50,000

Deadline: 27 Aug 2018

Indirect Overhead Rate: 0%

 

Myriad Genetics Ovarian Cancer Research Grant

Society of Gynecologic Oncology/Foundation for Women’s Cancer

Amount: $50,000

Deadline: 27 Aug 2018

Indirect Overhead Rate: 0%

 

St. Louis Ovarian Cancer Awareness Research Grant

Society of Gynecologic Oncology/Foundation for Women’s Cancer

Amount: $50,000

Deadline: 27 Aug 2018

Indirect Overhead Rate: 0%

 

Post-Doctoral Fellowship Award

Society of Gynecologic Oncology/Foundation for Women’s Cancer

Amount: $202,500

Deadline: 27 Aug 2018

Indirect Overhead Rate: 0%

 

Laura Crandall Brown Foundation Ovarian Cancer Early Detection Research Grant

Society of Gynecologic Oncology/Foundation for Women’s Cancer

Amount: $50,000

Deadline: 27 Aug 2018

Indirect Overhead Rate: 0%

 

Clovis Oncology Post-Doctoral Fellowship Award

Society of Gynecologic Oncology/Foundation for Women’s Cancer

Amount: $202,500

Deadline: 27 Aug 2018

Indirect Overhead Rate: 0%

 

OREF/ASES/ROCKWOOD Clinical Research Grant in Shoulder Care

Orthopaedic Research and Education Foundation (OREF)

Amount: $50,000

Deadline: 03 Sep 2018

Indirect Overhead Rate: 0%

 

AAAAI Foundation Faculty Development Award

American Academy of Allergy, Asthma and Immunology (AAAAI)

Amount: $240,000

Deadline: 04 Sep 2018 LOI; 15 Nov 2018 Application

Indirect Overhead Rate: 0%

 

Clinical Research Training Fellowship in Tourette Syndrome

American Academy of Neurology (AAN)

Amount: $150,000

Deadline: 01 Oct 2018

Indirect Overhead Rate: 0%

 

Clinical Research Training Scholarship in ALS

American Academy of Neurology (AAN)

Amount: $150,000

Deadline: 01 Oct 2018

Indirect Overhead Rate: 0%

 

Robert W. Katzman, MD, Clinical Research Training Scholarship in Alzheimer’s and Dementia Research

American Academy of Neurology (AAN)

Amount: $150,000

Deadline: 01 Oct 2018

Indirect Overhead Rate: 0%

 

Richard Olney Clinician Scientist Development Award in ALS

American Academy of Neurology (AAN)

Amount: $240,000

Deadline: 01 Oct 2018

Indirect Overhead Rate: 0%

 

Clinical Research Training Fellowship in Muscular Dystrophy

American Academy of Neurology (AAN)

Amount: $150,000

Deadline: 01 Oct 2018

Indirect Overhead Rate: 0%

 

Postdoctoral Research Fellowships

Cystic Fibrosis Foundation (CFF)

Amount: $102,000

Deadline: 03 Dec 2018

Indirect Overhead Rate: 0%

Fritz Thyssen Stiftung / Thyssen Foundation Stipends (Scholarships)
Amount: Approximately $460,000
Deadline: Continuously accepting applications

Boston Biomedical Innovation Center (B-BIC) Encouraging PILOT & DRIVE Grant Submissions
Deadline: None
Amount: $50,000 or $200,000

FY17 DoD DMRDP Program Announcements
Deadline: Varies by Program
Amount: Varies by Program

Fox Foundation for Parkinson’s Research, Michael J. (MJFF) Alpha-Synuclein Imaging Prize
Deadline: There is no deadline for submissions. The $2 million award will be issued to the first contestant 
who submits compelling evidence of a viable selective tracer and agrees to its widespread use.
Amount: $2,000,000

NIH Research Supplements to Promote Diversity in Health-Related Research
Deadline: Six per year
Amount: Direct costs for individual administrative supplements vary from less than $5,000 to more than $100,000 depending on the career level of the candidate.

Partnership for Clean Competition Micro-Grants 
Deadline: Ongoing
Amount: $74,999
Indirect Overhead Rate: undetermined

Brain Tumour Charity Clinical Biomarkers Awards
Deadline: Proposals accepted on a rolling basis
Amount: 500,000 GBP
Indirect Overhead Rate: 0%

Pediatric Low Grade Astrocytoma Foundation Research Grants
Deadline: Ongoing
Amount:$100,000-$500,000
Indirect Overhead Rate: 0%

Fritz Thyssen Foundation  Stipends (Scholarships)
Deadline: Ongoing
Amount: €408,000EUR
Indirect overhead rate: 0%

Therapeutic Development Initiative (TDI) – Funding for High-Impact Pediatric Cancer Research
Solving Kids’ Cancer
Deadline: Ongoing
Amount: $50,000-600,000
Indirect Overhead Rate: 0%

Hilda & Preston Davis Foundation Grant
Deadline: Continuous
Amount: $100,000
Indirect Overhead Rate: 0%

 

Ralph I. Straus Award for Multiple Sclerosis
National Multiple Sclerosis Society
Amount: $1,000,000
Deadline: Continuous


Request for Blepharospasm/Meige Research Proposals
Benign Essential Blepharospasm Research Foundation, Inc.
Amount: $100,000
Deadline: 31 Aug 2018
Indirect Overhead Rate: 0%

 

Grants
Draper Richards Foundation
Amount: $300,000
Deadline: Ongoing

 

AIDS Research
Robert Mapplethorpe Foundation
Amount: $50,000
Deadline: Continuous
Indirect Overhead Rate: Not listed

 
Clinical Research: Clinical Research Training Scholarships
Muscular Dystrophy Association (MDA)
Amount: $130,000
Deadline: 01 Oct 2018
Indirect Overhead Rate: 0%
 
Clinical Research: Clinical Research Network Grants
Muscular Dystrophy Association (MDA)
Amount: $60,000
Deadline: Ongoing
Indirect Overhead Rate: 10%


Clinical Research: Clinical Research Training Scholarships
Muscular Dystrophy Association (MDA)
Amount: $130,000
Deadline: 01 Oct 2018
Indirect Overhead Rate: 0%

Clinical Research: Clinical Research Network Grants
Muscular Dystrophy Association (MDA)
Amount: $60,000
Deadline: Ongoing
Indirect Overhead Rate: 10%


Internal Coordination
Translational Research Grants
Harry J. Lloyd Charitable Trust
Amount: $125,000
Deadline: 10 Nov 2018
Indirect Overhead Rate: 0%

 

AOTF Intervention Research Grant Program
American Occupational Therapy Association (AOTA)
Amount: $50,000
Deadline: 24 Aug 2018
Indirect Overhead Rate: 10%

 

AACR Basic Cancer Research Fellowships
American Association for Cancer Research (AACR)
Amount: $50,000
Deadline: 27 Sep 2018
Indirect Overhead Rate: 0%

 

Special Initiatives: The Social, Economic and Political Effects of the Affordable Care Act
Russell Sage Foundation
Amount: $150,000
Deadline: 20 Aug 2018 LOI; 15 Nov 2018 Proposal
Indirect Overhead Rate: 15%

 

Pilot and Exploratory Project Support Grant
National Palliative Care Research Center (NPCRC)
Amount: $154,000
Deadline: 07 Nov 2018
Indirect Overhead Rate: 10%

 

Junior Faculty Career Development Award
National Palliative Care Research Center (NPCRC)
Amount: $154,000
Deadline: 07 Nov 2018
Indirect Overhead Rate: 10%

 

Research Starter Grants – Pharmacology / Toxicology
Pharmaceutical Research and Manufacturers of America Foundation, Inc. (PhRMA Foundation)
Amount: $100,000
Deadline: 01 Sep 2018
Indirect Overhead Rate: 0%

 

Post Doctoral Fellowship – Pharmacology / Toxicology
Pharmaceutical Research and Manufacturers of America Foundation, Inc. (PhRMA Foundation)
Amount: $80,000
Deadline: 01 Sep 2018
Indirect Overhead Rate: 0%

 

Research Starter Grants – Informatics
Pharmaceutical Research and Manufacturers of America Foundation, Inc. (PhRMA Foundation)
Amount: $100,000
Deadline: 01 Sep 2018
Indirect Overhead Rate: 0%

 

Post Doctoral Fellowships – Informatics
Pharmaceutical Research and Manufacturers of America Foundation, Inc. (PhRMA Foundation)
Amount: $80,000
Deadline: 01 Sep 2018
Indirect Overhead Rate: 0%

 

Research Starter Grant – Pharmaceutics
Pharmaceutical Research and Manufacturers of America Foundation, Inc. (PhRMA Foundation)
Amount: $100,000
Deadline: 01 Sep 2018
Indirect Overhead Rate: 0%

 

Post Doctoral Fellowships – Pharmaceutics
Pharmaceutical Research and Manufacturers of America Foundation, Inc. (PhRMA Foundation)
Amount: $80,000
Deadline: 01 Sep 2018
Indirect Overhead Rate: 0%

 

Clinical Biomarkers Awards
Brain Tumour Charity
Amount: £500,000 GBP
Deadline: 3 September 2018
Indirect Overhead Rate: 0%

 

Request for Basic Scientific & Clinical Research Proposals
ASXL Rare Research Endowment Foundation
Amount: $200,000
Deadline: 15 Sep 2018
Indirect Overhead Rate: 10%

 

Clinic and Laboratory Integration Program (CLIP) Grants
Cancer Research Institute (CRI)
Amount: $200,000
Deadline: 01 Nov 2018
Indirect Overhead Rate: 0%

 

Technology Impact Award
Cancer Research Institute (CRI)
Amount: $200,000
Deadline: 01 Nov 2018
Indirect Overhead Rate: 0%

 

SWOG Trial Support (STrS)
The Hope Foundation
Amount: $150,000
Deadline: Ongoing
Indirect Overhead Rate: Not listed

 

Collaborative Sciences Award
American Heart Association (AHA)
Amount: $750,000
Deadline: 09 Oct 2018 LOI; 31 Jan 2019 Application
Indirect Overhead Rate: 10%

 

Career Development Award
American Heart Association (AHA)
Amount: $231,000
Deadline: 17 Oct 2018
Indirect Overhead Rate: 10%

 

Established Investigator Award
American Heart Association (AHA)
Amount: $400,000
Deadline: 23 Oct 2018 LOI; 15 Jan 2019 Application
Indirect Overhead Rate: 10%

 

Innovative Project Award
American Heart Association (AHA)
Amount: $200,000
Deadline: 29 Oct 2018 LOI; 17 Jan 2019 Application
Indirect Overhead Rate: 10%

Transformational Project Award
American Heart Association (AHA)
Amount: $300,000
Deadline: 23 Jan 2019
Indirect Overhead Rate: 10%

 

Institutional Challenge Grant
William T. Grant Foundation
Amount: $650,000
Deadline: 07 Sep 2018
Indirect Overhead Rate: 15%

 

AACR Scientific Achievement Awards – Pezcoller Foundation-American Association for Cancer Research International Award for Extraordinary Achievement in Cancer Research
American Association for Cancer Research (AACR)
Amount: €75,000 EUR
Deadline: 12 Sep 2018

Pradel Research Award
National Academies of Sciences, Engineering, and Medicine
Amount: $50,000
Deadline: 01 Oct 2018

 

Clinical Investigator Career Development Award
Lymphoma Research Foundation (LRF)
Amount: $225,00
Deadline: 06 Sep 2018
Indirect Overhead Rate: 0%

Baillet Latour Health Prize
Fonds Baillet Latour
Amount: €250,000 EUR
Deadline: 30 Sep 2018

 

CONquer canCER Now Award
Concern Foundation
Amount: $120,000
Deadline: 09 Sep 2019 LOI; 07 Dec 2019 Full Proposal
Indirect Overhead Rate: 0%

 

Career Development Program: Scholar Award
Leukemia & Lymphoma Society (LLS)
Amount: $110,000
Deadline: 15 Sep 2018 Abstract Submission; 03 Oct 2018 Application
Indirect Overhead Rate: 5%

 

Career Development Program: Special Fellow
Leukemia & Lymphoma Society (LLS)
Amount: $201,000
Deadline: 15 Sep 2018 Abstract Submission; 03 Oct 2018 Application
Indirect Overhead Rate: 5%

 

Career Development Program: Scholar in Clinical Research
Leukemia & Lymphoma Society (LLS)
Amount: $625,000
Deadline: Deadline: 15 Sep 2018 Abstract Submission; 03 Oct 2018 Application
Indirect Overhead Rate: 5%

 

Clinical Biomarkers
Brain Tumour Charity
Amount:  £500,000 GBP
Deadline: 03 Sep 2018
Indirect Overhead Rate: 0%

 

Expanding Theories Awards
Brain Tumour Charity
Amount:  £120,000 GBP
Deadline: 03 Sep 2018
Indirect Overhead Rate: 0%

 

NEA Research Grant
National Eczema Association (NEA)
Amount: $75,000
Deadline: 14 Sep 2018
Indirect Overhead Rate: 0%

 

Research Grants
Oxalosis and Hyperoxaluria Foundation (OHF)
Amount: $200,000
Deadline: 01 Nov 2018
Indirect Overhead Rate: 0%

 

AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease
American Gastroenterological Association (AGA)
Amount: $270,000
Deadline: 14 Dec 2018
Indirect Overhead Rate: 0%

 

ACS Resident Research Scholarships
American College of Surgeons
Amount: $60,000
Deadline: 14 Sep 2018
Indirect Overhead Rate: 0%

 

ACCF/Merck Research Fellowships in Cardiovascular Disease and Cardiometabolic Disorders
American College of Cardiology (ACC)
Amount: $70,000
Deadline: 21 Sep 2018
Indirect Overhead Rate: 0%

Research Scholar Award (RSA)
American Gastroenterological Association (AGA)
Amount: $270,000
Deadline: 14 Dec 2018
Indirect Overhead Rate: 0%

X